ATXA Therapeutics Limited
2 clinical trials · Sponsor
◉ Watch ATXA Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose (NCT06092788) | ATXA Therapeutics Limited | 2023-11-24 |
| Safety, Tolerability and Pharmacokinetics of NTP42:KVA4 (NCT04919863) | ATXA Therapeutics Limited | 2021-05-24 |
Track ATXA Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.